Skip to main content
Equibles

UBS Group AG

Position in EW — Edwards Lifesciences Corp

CIK 1610520 ZURICH, V8
Back to EW Full portfolio

Position in EW

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$205,147,019
+$66,124,731 QoQ
Shares Held
2,561,776
+57.1% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 74.74822154630225.ToString("F0")% Shared 0.ToString("F0")% None 25.25177845369775.ToString("F0")%

Common Shares in EW Over Time

Shares Held

Position Value (USD)

Derivatives in EW

reported options exposure · as of Mar 31, 2026
CallValue
$10,394,384
CallShares
129,800
PutValue
$13,661,648
PutShares
170,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

UBS Group AG holds $5,239,528,751 across 130 Medical Devices names. EW ranks #6 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 12,152,765 $1,247,724,380
2 BSX
Boston Scientific Corp
 14,824,662 $930,247,536
3 MDT
Medtronic plc
 6,412,252 $555,621,633
4 SYK
Stryker Corp
 1,646,714 $541,093,748
5 DXCM
Dexcom Inc
 4,349,959 $273,177,422
6 EW
Edwards Lifesciences Corp
This page 		2,561,776 $205,147,019
7 GEHC
GE HealthCare Technologies Inc.
 2,805,315 $199,682,320
8 PEN
Penumbra Inc
 560,335 $183,997,200

All Filings in EW

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,661,648 170,600
2026-03-31 $10,394,384 129,800
2026-03-31 $205,147,019 2,561,776
2025-12-31 $139,022,288 1,630,760
2025-12-31 $17,732,000 208,000
2025-12-31 $10,894,950 127,800
2025-09-30 $18,509,260 238,000
2025-09-30 $159,890,060 2,055,935
2025-09-30 $12,412,092 159,600
2025-06-30 $9,924,849 126,900
2025-06-30 $1,665,873 21,300
2025-06-30 $143,632,268 1,836,495
2025-03-31 $163,797,115 2,259,894
2025-03-31 $6,523,200 90,000
2024-12-31 $198,847,907 2,686,045
2024-12-31 $12,133,517 163,900
2024-12-31 $740,300 10,000
2024-09-30 $118,132,323 1,790,155
2024-09-30 $659,900 10,000
2024-09-30 $5,939,100 90,000
2024-06-30 $923,700 10,000
2024-06-30 $153,139,295 1,657,890
2024-06-30 $6,927,750 75,000
2024-03-31 $135,904,091 1,422,186
2024-03-31 $4,300,200 45,000
2023-12-31 $108,214,302 1,419,204
2023-12-31 $5,718,750 75,000
2023-09-30 $4,336,928 62,600
2023-09-30 $2,078,400 30,000
2023-09-30 $164,216,875 2,370,336
2023-06-30 $223,565,302 2,370,034
2023-06-30 $3,075,158 32,600
2023-03-31 $177,655,308 2,147,411
2022-12-31 $172,365,437 2,310,219
2022-12-31 $22,383 300
2022-09-30 $195,711,629 2,368,530
2022-06-30 $239,053,973 2,513,976
2022-03-31 $3,578,688 30,400
2022-03-31 $294,062,790 2,497,985
2021-12-31 $25,910 200
2021-12-31 $370,532,818 2,860,153
2021-09-30 $295,599,230 2,611,070
2021-09-30 $33,963 300
2021-06-30 $31,071 300
2021-06-30 $285,053,949 2,752,283
2021-03-31 $25,092 300
2021-03-31 $214,838,874 2,568,614
2020-12-31 $27,369 300
2020-12-31 $209,571,182 2,297,174
2020-09-30 $161,827,386 2,027,404

Report a Problem

Category
Description
Email (optional, for follow-up)